|
WO2017147114A1
|
|
Diagnosing mild cognitive impairment (mci), predicting alzheimer's disease (ad) dementia onset, and screening and monitoring agents for treating mci or preventing dementia onset
|
|
EP3265810A1
|
|
Methods for classifying populations including alzheimer's disease populations
|
|
CA2935266A1
|
|
Convergence of aggregation rate with validated peripheral diagnostics for alzheimer's disease
|
|
BR112012007561A2
|
|
fibroblast development patterns for diagnosis of alzheimer's disease
|
|
EP3403650A2
|
|
Pkc-activating compounds for the treatment of neurodegenerative diseases
|
